This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Banking Remove Data Analysis Remove Dividends Related Topics
Price to Book Risk Premium Book Value Market Capitalization Enterprise Value Marketability Equity Treasury Corporate Finance Start-ups More Related Topics >
article thumbnail

“Shadow Trading” Becomes Insider Trading

Reynolds Holding

MARCH 28, 2022

The SEC’s complaint deemed him an “expert in the biopharmaceutical industry,” based on his undergraduate and graduate science degrees, a top-school MBA, and relevant work experience in investment banking and business development. At Medivation, he worked to expand its product and development pipeline through acquisitions and licensing.

Marketability 83
Marketability Banking Data Analysis Dividends 83
article thumbnail

Data Update 1 for 2021: A (Data) Look Back at a Most Forgettable Year (2020)!

Musings on Markets

JANUARY 9, 2021

In this post, I will start with a rationalization of why I do this data analysis every year, follow up with a description (geographic and sector) of the overall universe of companies that are in my analysis, list out the variables that I estimate and report, and conclude with a short caveat about 2020 data.

Risk Premium 52
Risk Premium Market Capitalization Equity Start-ups 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 8,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024